SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-14-000095
Filing Date
2014-11-07
Accepted
2014-11-07 16:56:54
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 ISIS PHARMACEUTICALS INC 10-Q 9-30-2014 form10q.htm 10-Q 1017501
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 160305
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 178890
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 30885
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 7690
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 7359
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 5610
  Complete submission text file 0000874015-14-000095.txt   8829118

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT isis-20140930.xml EX-101.INS 1437990
9 XBRL TAXONOMY EXTENSION SCHEMA isis-20140930.xsd EX-101.SCH 64450
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isis-20140930_cal.xml EX-101.CAL 58158
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isis-20140930_def.xml EX-101.DEF 374679
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE isis-20140930_lab.xml EX-101.LAB 772237
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isis-20140930_pre.xml EX-101.PRE 494091
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 141205613
SIC: 2834 Pharmaceutical Preparations